Figure 3

OS with respect to reduced eNOS or VEGF levels and reduced eNOS and VEGF levels in patients treated with CT + B ((A,C) respectively) or CT ((B,D) respectively).

OS with respect to reduced eNOS or VEGF levels and reduced eNOS and VEGF levels in patients treated with CT + B ((A,C) respectively) or CT ((B,D) respectively).